posted on Mar 30 by MedPage Today OB/Gyn in the Uncategorized category
BARCELONA (MedPage Today) -- Breast cancer patients on concomitant beta-blocker therapy had significantly better outcomes compared with other patients, including a reduced risk of metastasis and improved disease-specific survival, data from a retrospective study showed.